249 related articles for article (PubMed ID: 26540569)
1. Differentiation between genetic mutations of breast cancer by breath volatolomics.
Barash O; Zhang W; Halpern JM; Hua QL; Pan YY; Kayal H; Khoury K; Liu H; Davies MP; Haick H
Oncotarget; 2015 Dec; 6(42):44864-76. PubMed ID: 26540569
[TBL] [Abstract][Full Text] [Related]
2. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the effects of microbiome-related confounding factors on the reproducibility of the volatolomic test.
Leja M; Amal H; Lasina I; Skapars R; Sivins A; Ancans G; Tolmanis I; Vanags A; Kupcinskas J; Ramonaite R; Khatib S; Bdarneh S; Natour R; Ashkar A; Haick H
J Breath Res; 2016 Jun; 10(3):037101. PubMed ID: 27341527
[TBL] [Abstract][Full Text] [Related]
4. Detection of precancerous gastric lesions and gastric cancer through exhaled breath.
Amal H; Leja M; Funka K; Skapars R; Sivins A; Ancans G; Liepniece-Karele I; Kikuste I; Lasina I; Haick H
Gut; 2016 Mar; 65(3):400-7. PubMed ID: 25869737
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study.
Zhang Y; Guo L; Qiu Z; Lv Y; Chen G; Li E
J Clin Lab Anal; 2020 Dec; 34(12):e23526. PubMed ID: 33150682
[TBL] [Abstract][Full Text] [Related]
6. Unique volatolomic signatures of TP53 and KRAS in lung cells.
Davies MP; Barash O; Jeries R; Peled N; Ilouze M; Hyde R; Marcus MW; Field JK; Haick H
Br J Cancer; 2014 Sep; 111(6):1213-21. PubMed ID: 25051409
[TBL] [Abstract][Full Text] [Related]
7. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
8. Prediction of breast cancer risk with volatile biomarkers in breath.
Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
[TBL] [Abstract][Full Text] [Related]
9. Breath testing as potential colorectal cancer screening tool.
Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
[TBL] [Abstract][Full Text] [Related]
10. Exhaled Breath Markers for Nonimaging and Noninvasive Measures for Detection of Multiple Sclerosis.
Broza YY; Har-Shai L; Jeries R; Cancilla JC; Glass-Marmor L; Lejbkowicz I; Torrecilla JS; Yao X; Feng X; Narita A; Müllen K; Miller A; Haick H
ACS Chem Neurosci; 2017 Nov; 8(11):2402-2413. PubMed ID: 28768105
[TBL] [Abstract][Full Text] [Related]
11. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
12. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
13. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
14. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry.
Li J; Peng Y; Liu Y; Li W; Jin Y; Tang Z; Duan Y
Clin Chim Acta; 2014 Sep; 436():59-67. PubMed ID: 24815034
[TBL] [Abstract][Full Text] [Related]
15. Volatile markers of breast cancer in the breath.
Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Rahbari-Oskoui F; Wong C
Breast J; 2003; 9(3):184-91. PubMed ID: 12752626
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the genomic heterogeneity of multifocal breast cancer.
Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
[TBL] [Abstract][Full Text] [Related]
18. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
19. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
20. Breath analysis by mass spectrometry: a new tool for breast cancer detection?
Patterson SG; Bayer CW; Hendry RJ; Sellers N; Lee KS; Vidakovic B; Mizaikoff B; Gabram-Mendola SG
Am Surg; 2011 Jun; 77(6):747-51. PubMed ID: 21679645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
